Medical Research
(H41Z)
IRS Verified
DX Registered
990 on File
GLAUCOMA RESEARCH FOUNDATION
Financial strength (30%)
80/100
Reliability (20%)
55/100
Effectiveness (25%)
81/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$10.1M
Total Revenue
$9.1M
Total Expenses
$15.1M
Net Assets
11
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
84.2%
Fundraising Efficiency
241.1%
Operating Reserve
19.90x
Liability-to-Asset
8.8%
Revenue Diversification
90.8%
Executive Compensation
$948K
Compared with Peers
FY 2025
Compared with 132 similar organizations
(United States, Medical Research, $1M–$10M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
84.2% | 83.0% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
5.7% | 9.9% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
10.1% | 2.6% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
241.1% | 110.6% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
19.9 mo | 14.4 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
8.8% | 13.2% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
90.8% | 90.0% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
40.9% | 7.4% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
30.3% | 3.0% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
10.2% | 4.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $10.1M | $9.1M | $15.1M | 84.2% | 11 |
| 2024 | $7.2M | $7.0M | $13.5M | 85.2% | 12 |
| 2023 | $6.5M | $6.2M | $12.9M | 87.5% | 11 |
| 2022 | $10.8M | $4.9M | N/A | — | 9 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.